Affordable Access

deepdyve-link
Publisher Website

Expected population impacts of discontinued prostate-specific antigen screening.

Authors
  • Gulati, Roman1
  • Tsodikov, Alex
  • Etzioni, Ruth
  • Hunter-Merrill, Rachel A
  • Gore, John L
  • Mariotto, Angela B
  • Cooperberg, Matthew R
  • 1 Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Type
Published Article
Journal
Cancer
Publisher
Wiley (John Wiley & Sons)
Publication Date
Nov 15, 2014
Volume
120
Issue
22
Pages
3519–3526
Identifiers
DOI: 10.1002/cncr.28932
PMID: 25065910
Source
Medline
Keywords
License
Unknown

Abstract

Discontinuing PSA screening for all men may generate many avoidable cancer deaths. Continuing PSA screening for men aged <70 years could prevent greater than one-half of these avoidable cancer deaths while dramatically reducing overdiagnoses compared with continued PSA screening for all ages.

Report this publication

Statistics

Seen <100 times